Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease
Thimme R Bukh J Spangenberg HC et al Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease Proc Natl Acad Sci USA 2002 99 15661 8
Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset
Haslett PA Corral LG Albert M et al Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset J Exp Med 1998 187 1885 92
Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8+ T cells in vitro
Haslett PA Hanekom WA Muller G et al Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8+ T cells in vitro J Infect Dis 2003 187 946 55
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha
Corral LG Haslett PA Muller GW et al Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha J Immunol 1999 163 380 6
A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans
Verbon A Juffermans NP Speelman P et al A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans Antimicrob Agents Chemother 2000 44 2286 90
Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis
Tramontana JM Utaipat U Molloy A et al Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis Mol Med 1995 1 384 97
Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: A phase 2 randomized, double-blind, placebo-controlled study
Zein NN Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: A phase 2 randomized, double-blind, placebo-controlled study J Hepatol 2005 42 315 22
Thalidomide salvages lethal hepatic necroinflammation and accelerates recovery from cirrhosis in rats
Yeh TS Ho YP Huang SF et al Thalidomide salvages lethal hepatic necroinflammation and accelerates recovery from cirrhosis in rats J Hepatol 2004 41 606 12
